1 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
2 |
DOI: 10.1158/1538-7445.AM2015-4693
|
3 |
Clinical pipeline report, company report or official report of HaiHe Biopharma.
|
4 |
Clinical pipeline report, company report or official report of Astex Pharmaceuticals.
|
5 |
WO patent application no. 2013,1850,32, Nanotherapeutics for drug targeting.
|
6 |
ERK Mutations Confer Resistance to Mitogen-Activated Protein Kinase Pathway Inhibitors
|
7 |
National Cancer Institute Drug Dictionary (drug name JSI1187).
|
8 |
Corchorusin-D directed apoptosis of K562 cells occurs through activation of mitochondrial and death receptor pathways and suppression of AKT/PKB pathway. Cell Physiol Biochem. 2012;30(4):915-26.
|
9 |
Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors. J Med Chem. 2005 Feb 10;48(3):710-22.
|
|
|
|
|
|
|